Accuracy of clinical suspicion and pathologic diagnosis of Kaposi sarcoma in East Africa

Journal of Acquired Immune Deficiency Syndromes

Volumn 71, Issue 3, 2016, Pages 295-301

  Amerson, Erin ^a   Woodruff, Carina Martin ^b   Forrestel, Amy ^c   Wenger, Megan ^d   McCalmont, Timothy ^a   LeBoit, Philip ^a   Maurer, Toby ^a   Laker Oketta, Miriam ^d,e   Muyindike, Winnie ^e,f   Bwana, Mwebesa ^f   Buziba, Nathan ^g,h   Busakhala, Naftali ^h,i   Wools Kaloustian, Kara ^i,j   Martin, Jeffrey ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e MAKERERE UNIVERSITY   (Uganda)

^f MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

^g MOI UNIVERSITY   (Kenya)

^h ACADEMIC MODEL PROVIDING ACCESS TO HEALTHCARE AMPATH   (Kenya)

ⁱ MOI TEACHING AND REFERRAL HOSPITAL   (Kenya)

^j INDIANA UNIVERSITY   (United States)

more..

Author keywords

Cancer; Dermatopathology; Diagnosis; Kaposi sarcoma; Pathology; Sub Saharan Africa

Indexed keywords

ADULT; AFRICA; ARTICLE; BACILLARY ANGIOMATOSIS; CANCER DIAGNOSIS; CUTANEOUS CRYPTOCOCCOSIS; DERMATOFIBROMA; DIAGNOSTIC ACCURACY; GOLD STANDARD; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; KENYA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PSORIASIS; PUNCH BIOPSY; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; SKIN CARCINOMA; SKIN LYMPHOMA; UGANDA; VERRUCA VULGARIS; BIOPSY; COMPLICATION; PATHOLOGY; SARCOMA, KAPOSI;

BIOPSY; HIV INFECTIONS; HUMANS; KENYA; SARCOMA, KAPOSI; SENSITIVITY AND SPECIFICITY; UGANDA;

EID: 84959128437     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000862     Document Type: Article

References (27)

1. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med. 1995;332:1181-1185.
2. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No.11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available at: http://globocan.iarc.fr. Accessed April 30, 2015.
3. Asiimwe SB, Laker-Oketta M, Bennett JP, et al. Impact of Kaposi's sarcoma on survival in HIV-infected African adults on antiretroviral therapy. Paper presented at: 21st Conference on Retroviruses and Opportunistic Infections; March 3-6, 2014; Boston, MA.
4. Maskew M, Fox MP, van Cutsem G, et al. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study. PLoS One. 2013;8:e64392.
5. Makombe SD, Harries AD, Yu JK, et al. Outcomes of patients with Kaposi's sarcoma who start antiretroviral therapy under routine programme conditions in Malawi. Trop Doct. 2008;38:5-7.
6. Chu KM, Mahlangeni G, Swannet S, et al. AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa. J Int AIDS Soc. 2010;13:23.
7. Banda LT, Parkin DM, Dzamalala CP, et al. Cancer incidence in Blantyre, Malawi 1994-1998. Trop Med Int Health. 2001;6:296-304.
8. Tsang MW, Kovarik CL. Global access to dermatopathology services: physician survey of availability and needs in sub-Saharan Africa. J Am Acad Dermatol. 2010;63:346-348.
9. Kaschula RO. The practice of pathology in Africa. Arch Pathol Lab Med. 2013;137:752-755.
10. Adesina A, Chumba D, Nelson AM, et al. Improvement of pathology in sub-Saharan Africa. Lancet Oncol. 2013;14:e152-e157.
11. International Epidemiologic Databases to Evaluate AIDS-East Africa [Internet]. Available at: https://www.iedea-ea.org. Accessed April 30, 2015.
12. Egger M, Ekouevi DK, Williams C, et al. Cohort profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa. Int J Epidemiol. 2012;41:1256-1264.
13. Laker-Oketta M, Wenger M, Semeere A, et al. Task shifting and skin punch for the histologic diagnosis of Kaposi's sarcoma in sub-Saharan Africa: a public health solution to a public health problem. Oncology. 2015;89:59-64.
14. Berger TG, Tappero JW, Kaymen A, et al. Bacillary (epithelioid) angiomatosis and concurrent Kaposi's sarcoma in acquired immunodeficiency syndrome. Arch Dermatol. 1989;125:1543-1547.
15. LeBoit P, Egbert B, Stoler M, et al. Epithelioid haemangioma-like vascular proliferation in AIDS: manifestation of cat scratch disease bacillus infection? Lancet. 1988;331:960-963.
16. LeBoit P. Proliferations of spindled cells. Am J Dermatopathol. 2001;23: 158-159.
17. Van Bogaert LJ. Clinicopathological proficiency in the diagnosis of Kaposi's sarcoma. ISRN AIDS. 2012;2012:e565463.
18. Tsang MW, Kovarik CL. The role of dermatopathology in conjunction with teledermatology in resource-limited settings: lessons from the African teledermatology project. Int J Dermatol. 2011;50:150-156.
19. Ogwang MD, Zhao W, Ayers LW, et al. Accuracy of burkitt lymphoma diagnosis in constrained pathology settings: importance to epidemiology. Arch Pathol Lab Med. 2011;135:445-450.
20. Orem J, Sandin S, Weibull CE, et al. Agreement between diagnoses of childhood lymphoma assigned in Uganda and by an international reference laboratory. Clin Epidemiol. 2012;4:339-347.
21. Wamala D, Katamba A, Dworak O. Feasibility and diagnostic accuracy of internet-based dynamic telepathology between Uganda and Germany. J Telemed Telecare. 2011;17:222-225.
22. Ramdial PK. Dermatopathological challenges in the human immunodeficiency virus and acquired immunodeficiency syndrome era. Histopathology. 2010;56:39-56.
23. Hong A, Davies S, Lee CS. Immunohistochemical detection of human herpesvirus 8 (HHV8) latent nuclear antigen-1 in Kaposi's sarcoma. Pathology. 2003;35:448-450.
24. Hammock L, Reinsauer A, Wang W, et al. Latency-associated nuclear antigen expression and human herpesvirus-8 polymerase chain reaction in the evaluation of Kaposi sarcoma and other vascular tumors in HIVpositive patients. Mod Pathol. 2005;18:463-468.
25. Vento S. Cancer control in Africa: which priorities? Lancet Oncol. 2013; 14:277-279.
26. Weinstein RS, Graham AR, Lian F, et al. Reconciliation of diverse telepathology system designs. Historic issues and implications for emerging markets and new applications. APMIS. 2012;120:256-275.
27. Bray F, Jemal A, Grey N, et al. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol. 2012;13:790-801.